Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1457 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Caraco Pharma names new CEO

Singh will assume the responsibilities following the resignation of Jitendra Doshi as interim CEO and as a director, effective 1 November 2010. Singh has served Caraco Pharma as

Amgen releases AMG 386 Phase 2 trial results

AMG 386 is an investigational peptibody that is designed to block angiogenesis by inhibiting angiopoietin-1 and -2 (Ang1 and Ang2). In the trial, overall survival in the 10mg/kg

Abbott to recall Meridia from US market

SCOUT (Sibutramine Cardiovascular OUTcome Trial) study, 6-year study requested by European regulatory authorities as a post-marketing commitment to evaluate cardiovascular safety in high-risk patients, is the basis for

Aurobindo Pharma names new CEO for API & CRAMS

Govindarajan will oversee active pharmaceutical ingredients (APIs) Operations and CRAMS development business at Aurobindo. He will be reporting to the managing director of the company. Most recently, Govindarajan